WAT vs IDXX
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
WAT · Waters$440.45 ▼ 3.51%
IDXX · IDEXX Laboratories Inc$676.21 ▼ 1.95%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- WAT +10.2%
- IDXX -10.1%
Head to head
| Metric | WAT | IDXX |
|---|---|---|
| Price | $440.45 | $676.21 |
| Change today | ▼ 3.51% | ▼ 1.95% |
| Market cap | $43.29B | $53.28B |
| Return, 3 months | +7.2% | +20.9% |
| Return, year to date | +16.0% | 0.0% |
| Return, 1 year | +11.8% | -6.8% |
| P/E (TTM) | 184.3 | 45.6 |
| P/B | 2.8 | 28.5 |
| P/E percentile vs own 5y | 99th | 34th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +120.9% | +9.9% |
| Net profit growth (YoY) | -45.6% | +15.5% |
| Gross margin | 49.5% | 62.7% |
| Operating margin | 5.8% | 32.3% |
| Net margin | 1.8% | 25.4% |
| Return on equity | 1.1% | 68.9% |
| Analyst target vs. price | +14.4% | +10.2% |
| Analyst buy share | 73% | 75% |
| RSI (14) | 44 | 60 |
| 30-day volatility | 33.7% | 65.4% |
| Max drawdown, 1 year | -31.3% | -34.2% |
| Trend read | Leaning bearish | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- IDXX is the largest of the group by market value.
- WAT has returned the most over the past year.
- IDXX carries the lowest trailing P/E.
- WAT is growing revenue fastest.
- IDXX keeps the most profit per dollar of sales.
- WAT has been the calmest stock over the last 30 days.